A
LYEL icon

Apoletto’s Lyell Immunopharma LYEL Stock Holding History

Apoletto’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$111M Hold
754,698
– – 42.56% 1
2022
Q2 		$98.4M Hold
754,698
– – 27.22% 2
2022
Q1 		$76.2M Hold
754,698
– – 20.06% 2
2021
Q4 		$117M Sell
754,698
-3,690
-0.5% -$823K 14.55% 3
2021
Q3 		$224M Hold
758,388
– – 30.66% 2
2021
Q2 		$246M Buy
+758,388
New +$249M 32.33% 2

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Apoletto's LYEL Position: Q3 2022 in Review

Apoletto held its Lyell Immunopharma (LYEL) position steady in Q3 2022 at 754,698 shares worth $111M. The position accounts for 42.56% of the portfolio, ranked #1.

Apoletto first reported a position in LYEL in Q2 2021 and has held it in 6 quarters since. The position peaked at $246M in Q2 2021. 93 funds tracked by Wall St. Rank hold LYEL as of Q3 2022.

  • Apoletto held 754,698 shares of Lyell Immunopharma worth $111M as of Q3 2022.
  • Apoletto left its Lyell Immunopharma share count unchanged in Q3 2022.
  • Lyell Immunopharma made up 42.56% of Apoletto's portfolio in Q3 2022, its #1 holding.
  • Apoletto first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 6 quarters since.
  • Apoletto's Lyell Immunopharma position peaked at $246M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2022.

Based on Apoletto's 13F filing for Q3 2022, filed 14 Nov 2022.